GHK-Cu is commonly injected subcutaneously at doses of 1-4 mg daily for systemic effects (skin, hair, wound healing)
A blood test can be helpful to confirm deficiency, but it is not always required
The compound has since remained an active subject of preclinical research, particularly in the areas of lipid metabolism, adipose tissue signaling, and exploratory tissue repair models
AOD 9604 (an abbreviation for Anti-Obesity Drug 9604) was first developed in the 1990s in Australia in the laboratory of Professor Frank Ng, a biochemist with a long research focus on growth hormone biology
Often, some people may use vitamin B12 if feeling weak due to megaloblastic anemia
This makes the discussion of 5-Amino-1MQ oral vs injectable particularly acute